Abstract
Background Muscle mass loss may be associated with liver fat accumulation, yet scientific consensus is lacking and evidence in older adults is scant. It is unclear which muscle characteristics might contribute to this association in older adults.
Methods We associated comprehensive muscle-related phenotypes including muscle mass normalized to body weight (D3-creatine dilution), muscle fat infiltration (MRI), carbohydrate-supported muscle mitochondrial maximal oxidative phosphorylation (respirometry), and cardiorespiratory fitness (VO2 peak) with liver fat among older adults. Linear regression models adjusted for age, gender, technician (respirometry only), daily minutes of moderate to vigorous physical activity, and prediabetes/diabetes status tested main effects and interactions of each independent variable with waist circumference (high: women—≥88 cm, men—≥102 cm) and gender.
Results Among older adults aged 75 (IQR 73, 79 years; 59.8% women), muscle mass and liver fat were not associated overall but were positively associated among participants with a high waist circumference (β: 25.2; 95%CI 11.7, 40.4; p=.0002; N=362). Muscle fat infiltration and liver fat were positively associated (β: 15.2; 95%CI 6.8, 24.3; p=.0003; N=378). Carbohydrate-supported maximum oxidative phosphorylation and VO2 peak (adjusted β: −12.9; 95%CI −20.3, −4.8; p=0.003; N=361) were inversely associated with liver fat; adjustment attenuated the estimate for maximum oxidative phosphorylation although the point estimate remained negative (β: −4.0; 95%CI −11.6, 4.2; p=0.32; N=321).
Conclusions Skeletal muscle-related characteristics are metabolically relevant factors linked to liver fat in older adults. Future research should confirm our results to determine whether trials targeting mechanisms common to liver and muscle fat accumulation are warranted.
Competing Interest Statement
SRC and Peggy MC are consultants to Bioage Labs. JL is an employee of AMRA Medical AB and reports consultancy/speaking honoraria from Eli Lilly and BioMarin. All other authors report no conflict of interest.
Funding Statement
SOMMA is funded by the National Institute on Aging grant number R01AG059416. Study infrastructure support was funded in part by National Institute on Aging Claude D. Pepper Older American Independence Centers at University of Pittsburgh (P30AG024827), Wake Forest University School of Medicine (P30AG021332), and the Clinical and Translational Science Institutes which is funded by the National Center for Advancing Translational Science at Wake Forest (UL1TR001420).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All research was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent, and the study was approved by the WIRB-Copernicus Group Institutional Review Board (20180764) for all participating sites (the data included in the present study were obtained only at Wake Forest University, but the University of Pittsburg also enrolled participants not included in this analysis).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The data that support the findings of this study are available from the Study of Muscle, Mobility and Aging (SOMMA). As of August 10th, 2023, data can be obtained via https://sommaonline.ucsf.edu
List of Abbreviations
- NAFLD
- non-alcoholic fatty liver disease
- SOMMA
- Study of Muscle, Mobility and Aging
- MRS
- magnetic resonance spectroscopy
- BMI
- body mass index
- CPET
- Cardiopulmonary Exercise Testing
- Max OXPHOS
- maximal oxidative phosphorylation
- ATPmax
- maximum adenosine triphosphate production
